| Dr Ajay Kumar, MD | |
|
301 E Wendover Ave Ste 211, Greensboro, NC 27401-1232 | |
| (336) 832-3088 | |
| (336) 832-3080 |
| Full Name | Dr Ajay Kumar |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 46 Years |
| Location | 301 E Wendover Ave Ste 211, Greensboro, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962426817 | NPI | - | NPPES |
| 8950458 | Medicaid | NC | |
| 50458 | Other | NC | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 29935 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Moses H. Cone Memorial Hospital, The | Greensboro, NC | Hospital |
| Bon Secours Community Hospital | Port jervis, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Moses Cone Medical Services Inc | 2769395458 | 176 |
News Archive
Accelerated partial breast irradiation was designed to be a faster, more convenient, and potentially safer way for many women with breast cancer to reduce their mortality risk and help keep their cancer from returning after surgery. But a new study shows that the availability of the approach is failing to reduce the percentage of early-stage breast cancer patients who do not receive the radiation treatment that could save their lives.
iBio, Inc. today announced the grant of a commercial, royalty-bearing license to Fiocruz/Bio-Manguinhos of Brazil to develop, manufacture and sell certain vaccines based upon iBio's proprietary technology. Fiocruz/Bio-Manguinhos will invest more than $6 million to bring the first product - a new yellow fever vaccine - through Phase I clinical trials.
Medical device company Vertos Medical Inc. has announced the completion of enrollment in its post-market U.S. IRB (Institutional Review Board) I Patient Outcomes Trial, a 75-patient study of the mild procedure. The open-label, single-arm, prospective, IRB-approved study is intended to gather patient outcomes data following treatment for symptomatic central canal spinal stenosis using proprietary mild devices. Results from the trial, which is being conducted by 14 investigators at academic and private practice settings across the United States, are expected to be published during 2010.
The Innovation and Technology Commission of the Hong Kong government has awarded Pangu BioPharma, the Hong Kong subsidiary of aTyr Pharma, a second grant to fund research it is performing in collaboration with the Hong Kong University of Science and Technology (HKUST). The Innovation and Technology Fund (ITF) provides matching funds over the next 18 months to expand Pangu's successful work in the identification and characterization of naturally occurring splice variants of human tRNA synthetases.
› Verified 7 days ago
| Entity Name | Moses Cone Medical Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427095249 PECOS PAC ID: 2769395458 Enrollment ID: O20040128000519 |
News Archive
Accelerated partial breast irradiation was designed to be a faster, more convenient, and potentially safer way for many women with breast cancer to reduce their mortality risk and help keep their cancer from returning after surgery. But a new study shows that the availability of the approach is failing to reduce the percentage of early-stage breast cancer patients who do not receive the radiation treatment that could save their lives.
iBio, Inc. today announced the grant of a commercial, royalty-bearing license to Fiocruz/Bio-Manguinhos of Brazil to develop, manufacture and sell certain vaccines based upon iBio's proprietary technology. Fiocruz/Bio-Manguinhos will invest more than $6 million to bring the first product - a new yellow fever vaccine - through Phase I clinical trials.
Medical device company Vertos Medical Inc. has announced the completion of enrollment in its post-market U.S. IRB (Institutional Review Board) I Patient Outcomes Trial, a 75-patient study of the mild procedure. The open-label, single-arm, prospective, IRB-approved study is intended to gather patient outcomes data following treatment for symptomatic central canal spinal stenosis using proprietary mild devices. Results from the trial, which is being conducted by 14 investigators at academic and private practice settings across the United States, are expected to be published during 2010.
The Innovation and Technology Commission of the Hong Kong government has awarded Pangu BioPharma, the Hong Kong subsidiary of aTyr Pharma, a second grant to fund research it is performing in collaboration with the Hong Kong University of Science and Technology (HKUST). The Innovation and Technology Fund (ITF) provides matching funds over the next 18 months to expand Pangu's successful work in the identification and characterization of naturally occurring splice variants of human tRNA synthetases.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ajay Kumar, MD Po Box 14883, Greensboro, NC 27415-4883 Ph: (336) 378-1076 | Dr Ajay Kumar, MD 301 E Wendover Ave Ste 211, Greensboro, NC 27401-1232 Ph: (336) 832-3088 |
News Archive
Accelerated partial breast irradiation was designed to be a faster, more convenient, and potentially safer way for many women with breast cancer to reduce their mortality risk and help keep their cancer from returning after surgery. But a new study shows that the availability of the approach is failing to reduce the percentage of early-stage breast cancer patients who do not receive the radiation treatment that could save their lives.
iBio, Inc. today announced the grant of a commercial, royalty-bearing license to Fiocruz/Bio-Manguinhos of Brazil to develop, manufacture and sell certain vaccines based upon iBio's proprietary technology. Fiocruz/Bio-Manguinhos will invest more than $6 million to bring the first product - a new yellow fever vaccine - through Phase I clinical trials.
Medical device company Vertos Medical Inc. has announced the completion of enrollment in its post-market U.S. IRB (Institutional Review Board) I Patient Outcomes Trial, a 75-patient study of the mild procedure. The open-label, single-arm, prospective, IRB-approved study is intended to gather patient outcomes data following treatment for symptomatic central canal spinal stenosis using proprietary mild devices. Results from the trial, which is being conducted by 14 investigators at academic and private practice settings across the United States, are expected to be published during 2010.
The Innovation and Technology Commission of the Hong Kong government has awarded Pangu BioPharma, the Hong Kong subsidiary of aTyr Pharma, a second grant to fund research it is performing in collaboration with the Hong Kong University of Science and Technology (HKUST). The Innovation and Technology Fund (ITF) provides matching funds over the next 18 months to expand Pangu's successful work in the identification and characterization of naturally occurring splice variants of human tRNA synthetases.
› Verified 7 days ago
Dr. Olugbemiga Ebenezer Jegede, M.D Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 201 E Wendover Ave, Greensboro, NC 27401 Phone: 336-832-4444 Fax: 336-832-4445 | |
Yan Feng, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 501 N Elam Ave, Greensboro, NC 27403 Phone: 336-832-1100 | |
Dr. Gary Bradley Sherrill, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 501 N Elam Ave, Greensboro, NC 27403 Phone: 336-832-1100 | |
Edwin Aziegbe Avbuere, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3231 Yanceyville Street, Greensboro, NC 27405 Phone: 336-358-1528 Fax: 336-358-1582 | |
Dr. Jay Krishnavadan Patel, MB.CHB Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 309 New St, Carolina Kidney Associates, Greensboro, NC 27405 Phone: 336-379-9708 Fax: 336-553-2085 | |
Gayatri A Acharya, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3200 Northline Ave Ste 250, Greensboro, NC 27408 Phone: 336-273-7900 | |
Murali Ramaswamy, MD FAAFP Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 520 N Elam Ave, Greensboro, NC 27403 Phone: 336-547-1801 Fax: 336-547-1828 |